CBD-enriched medical cannabis for intractable pediatric epilepsy-Reference-Cited by-同舟云学术

CBD-enriched medical cannabis for intractable pediatric epilepsy

Published:2016-02 Issue: Volume:35 Page:41-44
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Tzadok Michal,Uliel-Siboni Shimrit,Linder Ilan,Kramer Uri,Epstein Orna,Menascu Shay,Nissenkorn Andrea,Yosef Omer Bar,Hyman Eli,Granot Dorit,Dor Michael,Lerman-Sagie Tali,Ben-Zeev Bruria

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference26 articles.

1. Early identification of refractory epilepsy;Kwan;N Engl J Med,2000

2. Definition of drug resistant epilepsy: consensus proposal of the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies;Kwan;Epilepsia,2010

3. Diagnosing refractory epilepsy: response to sequential treatment schedules;Mohanraj;Eur J Neurol,2006

4. Supply and demand for endocannabinoids;Alger;Trends Neurosci,2011

5. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders;Devinsky;Epilepsia,2014

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of artisanal and non-regulated cannabis-based products for the treatment of epilepsy in a low-income population;Epilepsy & Behavior;2024-10

2. Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke;International Journal of Molecular Sciences;2024-06-18

3. Cannabidiol‐enriched oil for adult patients with drug‐resistant epilepsy: Prospective clinical and electrophysiological study;Epilepsia;2024-05-29

4. The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders;International Journal of Molecular Sciences;2024-05-25

5. Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial;Psychopharmacology;2024-05-17